| Literature DB >> 30348170 |
Robert D Ashford1, Brenda Curtis2, Austin M Brown3.
Abstract
BACKGROUND: Recovery from substance use disorder (SUD) is often considered at odds with harm reduction strategies. More recently, harm reduction has been categorized as both a pathway to recovery and a series of services to reduce the harmful consequences of substance use. Peer recovery support services (PRSS) are effective in improving SUD outcomes, as well as improving the engagement and effectiveness of harm reduction programs.Entities:
Keywords: Harm reduction; Intravenous substance use; Peer recovery support services; Recovery community organizations; Syringe exchange
Mesh:
Substances:
Year: 2018 PMID: 30348170 PMCID: PMC6198436 DOI: 10.1186/s12954-018-0258-2
Source DB: PubMed Journal: Harm Reduct J ISSN: 1477-7517
Fig. 1Peer SEP, RCO, and hybrid RCO comparison models. SEP = syringe exchange program; RCO = recovery community organization
Fig. 2Zip code heat map of intravenous substance use of participants
Participant characteristics
| ( | ||
|---|---|---|
|
| (%) | |
| Age (years) | ||
| Gender | ||
| Male | 244 | (58.5) |
| Female | 166 | (39.8) |
| Other | 7 | (1.7) |
| Race/ethnicity | ||
| White | 279 | (66.9) |
| Black | 99 | (23.7) |
| Multi-racial | 29 | (7.0) |
| Other | 10 | (2.4) |
| Sexual orientation | ||
| Heterosexual | 354 | (84.9) |
| Bisexual | 32 | (7.7) |
| Homosexual | 31 | (7.5) |
| Housing status | ||
| Stable housing | 233 | (55.9) |
| Homeless | 92 | (22.1) |
| Transitional housing | 11 | (2.6) |
| Couch surfing | 62 | (14.9) |
| Unknown | 19 | (4.6) |
| HIV status | ||
| Positive | 13 | (3.1) |
| HCV status | ||
| Positive | 142 | (34.1) |
| Probation/parole status | ||
| Currently on | 36 | (8.6) |
| Previously on | 123 | (29.5) |
| Medical diagnosis | ||
| Mental health diagnosis | 56 | (13.4) |
| Diabetes | 7 | (1.7) |
| Infection | 13 | (3.1) |
| Multiple | 14 | (3.4) |
| Zip codes of highest use | ||
| 63111 | 71 | (17.0) |
| 63118 | 76 | (18.2) |
| 63116 | 28 | (6.7) |
| Multiple engagements at RCO | ||
| Yes | 149 | (35.7) |
| Total number of participants ( | ||
| Total Narcan dispensed | ||
| IM | 9 | – |
| Nasal | 99 | – |
| Narcan administered* | ||
| Yes and 911 called | 90 | (6.8) |
| Yes and 911 not called | 61 | (10.1) |
| Sterile syringes dispensed | ||
| Range 5345–8955 | – | – |
| Used syringes received | ||
| Range 600–1530 | – | – |
* n = 895 as result is calculated from all engagements with duplicate participants
Significant Monte Carlo chi-square test results from multiple participant variable pairs
| Variable pair | df |
|
|
| 99% CI (LL, UL) |
|---|---|---|---|---|---|
| Multiple peer engagements and housing status | 4 | 417 | 9.451 | .05 | (.049, .051) |
| Multiple peer engagements and probation/parole status | 3 | 417 | 30.194 | < .001 | (.000, .000) |
| Multiple peer engagements and previous health Dx | 6 | 417 | 32.485 | < .001 | (.000, .000) |
| Multiple peer engagements and race/ethnicity | 4 | 417 | 12.406 | .011 | (.010, .012) |
| Naloxone administration and probation/parole status | 2 | 417 | 22.693 | .007 | (.007, .008) |
| Naloxone administration and sexual orientation | 9 | 417 | 25.347 | .018 | (.017, .019) |
| Syringes received and HIV status | 4 | 417 | 17.013 | .024 | (.022, .025) |
| Syringes returned and HIV status | 6 | 417 | 14.042 | .04 | (.039, .042) |
df degrees of freedom, CI confidence interval, LL lower limit, UL upper limit, Dx diagnosis